BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 23390008)

  • 1. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
    Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
    AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
    Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
    Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
    Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
    Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of benign and malignant distal biliary strictures: value of adding diffusion-weighted imaging to conventional magnetic resonance cholangiopancreatography.
    Yoo RE; Lee JM; Yoon JH; Kim JH; Han JK; Choi BI
    J Magn Reson Imaging; 2014 Jun; 39(6):1509-17. PubMed ID: 24136813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm.
    Ogawa T; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Ito K; Koshita S; Kanno Y; Masu K; Sugita R
    J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):801-8. PubMed ID: 25082473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
    Kang KM; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
    Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography.
    Kim SH; Lee JM; Lee ES; Baek JH; Kim JH; Han JK; Choi BI
    Radiology; 2015 Mar; 274(3):723-33. PubMed ID: 25302831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of enhanced magnetic resonance imaging and magnetic resonance cholangiopancreatography in the differential diagnosis of benign and malignant intraductal papillary mucinous neoplasms of the pancreas].
    Qian HF; Li FQ; Hu CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Feb; 36(1):98-101. PubMed ID: 24581137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.
    Jang KM; Kim SH; Lee SJ; Park HJ; Choi D; Hwang J
    Radiology; 2013 Feb; 266(2):491-501. PubMed ID: 23238154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Zhang L; Rao SX; Xu XF; Wang DS; Jin da Y; Zeng MS
    Diagn Interv Radiol; 2016; 22(4):308-13. PubMed ID: 27283593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.